tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RCUS is currently covered by 9 analysts with an average price target of $32.56. This is a potential upside of $14.37 (10.45%) from yesterday's end of day stock price of $29.48.
Arcus Biosciences's activity chart (see below) currently has 109 price targets and 101 ratings on display. The stock rating distribution of RCUS is 77.27% BUY and 22.73% HOLD.
Analysts average stock forecasts to be materialized ratio is 44.48% with an average time for these price targets to be met of 269.21 days.
Highest price target for RCUS is $49, Lowest price target is $16, average price target is $32.56.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 06-Aug-2026. First documented stock forecast 09-Apr-2018.
Currently out of the existing stock ratings of RCUS, 17 are a BUY (77.27%), 5 are a HOLD (22.73%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Oct-2018
$43
$13.52 (45.86%)
$41
Hold Since 06-Aug-2026
$26
$-3.48 (-11.80%)
$23
Buy Since 03-Jun-2025
$45
$15.52 (52.65%)
$32
Hold Since 11-May-2026
$22
$-9 (-29.03%)
$20
Buy Since 24-May-2019
$45
$14 (45.16%)
$44
What is RCUS (Arcus Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?
Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?
Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?
Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?
